Plasma PCSK9 levels have been shown to serve as a late biomarker of the severity of illness in patients with severe trauma injury in ICU (56) and sepsis (57) and have been correlated to endothelial dysfunction in patients with chronic kidney disease (58). Here, PCSK9 is linked to chronic kidney disease.